1BGS image
Deposition Date 1993-11-02
Release Date 1994-04-30
Last Version Date 2024-02-07
Entry Detail
PDB ID:
1BGS
Keywords:
Title:
RECOGNITION BETWEEN A BACTERIAL RIBONUCLEASE, BARNASE, AND ITS NATURAL INHIBITOR, BARSTAR
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:BARNASE
Chain IDs:A, B, C
Chain Length:110
Number of Molecules:3
Biological Source:Bacillus amyloliquefaciens
Polymer Type:polypeptide(L)
Molecule:BARSTAR
Chain IDs:D (auth: E), E (auth: F), F (auth: G)
Chain Length:89
Number of Molecules:3
Biological Source:Bacillus amyloliquefaciens
Primary Citation
Recognition between a bacterial ribonuclease, barnase, and its natural inhibitor, barstar.
Structure 1 165 176 (1993)
PMID: 16100951 DOI: 10.1016/0969-2126(93)90018-C

Abstact

BACKGROUND Protein-protein recognition is fundamental to most biological processes. The information we have so far on the interfaces between proteins comes largely from several protease-inhibitor and antigen-antibody complexes. Barnase, a bacterial ribonuclease, and barstar, its natural inhibitor, form a tight complex which provides a good model for the study and design of protein-protein non-covalent interactions. RESULTS Here we report the structure of a complex between barnase and a fully functional mutant of barstar determined by X-ray analysis. Barstar is composed of three parallel alpha-helices stacked against a three-stranded parallel, beta-sheet, and sterically blocks the active site of the enzyme with an alpha-helix and adjacent loop. The buried surface in the interface between the two molecules totals 1630 A2. The barnase-barstar complex is predominantly stabilized by charge interactions involving positive charges in the active site of the enzyme. Asp39 of barstar binds to the phosphate-binding site of barnase, mimicking enzyme-substrate interactions. CONCLUSION The phosphate-binding site of the enzyme is the anchor point for inhibitor binding. We propose that this is also likely to be the case for other ribonuclease inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures